ImmunoChem/Phospho-Crebtide Antibody/100 µg/ICP0180
商品编号：
ICP0180
品牌：
immunechem
市场价：
¥7500.00
美元价：
3750.00
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
Phospho-Crebtide Antibody
|
Product Description | Crebtide (KRREILSRRPSYR) is a substrate peptide derived from the protein Creb which is widely utilized as a synthetic substrate for the PKA and PKC kinase families. Affinity purified rabbit polyclonal anti-pCrebtide is developed with phosphorylated Crebtide (KRREILSRRPpSYR) and absorbed with non-phosphorylated Crebtide. |  Western-blot analysis of the BSA-Crebtide phosphorylated with PKC alpha Kinase/assay  Western-blot analysis of the BSA-Crebtide phosphorylated with PKC alpha Kinase/assay: A: 0.0 ng B: 3 ng C: 6 ng D: 12.5 ng E: 25 ng F: 50 ng  Western-blot analysis of the BSA-Crebtide phosphorylated with PKC alpha Kinase/assay: A:0.0 ng B:4 ng C:15 ng D:60 ng E:250 ng. | |
Species | Rabbit | ||
Formulation | 250 µg/mL in TBS, 0.1% NaN3 | ||
Immunogen | Phospho-Crebtide (KRREILSRRPpSYR)-KLH | ||
Purification | The antibody was affinity purified with KRREILSRRPpSYR on agarose followed by affinity desorption with non-phosphorylated Crebtide. | ||
Specificity | The antibody recognizes only the phosphorylated Crebtide product of PKA and PKC in a non-radioactive kinase assay. There are no cross-reactions with the non-phosphorylated Crebtide. | ||
Applications | ELISA; WB; Non-radioactive PKA and PKC kinase assay | ||
Scientific Description | p33 (ING1) is a new growth inhibitor candidate for a tumour suppressor gene. p33 (ING1) cooperates with p53 and down-regulates cell growth by activating transcription from the p21/WAF1 promoter although there is no sequence similarity between p33 (ING1) and p53. | ||
Storage & Stability | Product is stable for several weeks at 4°C. For extended storage, aliquot content and store product at -20°C. Avoid cycles of freezing and thawing. Expiration date is one year from date of shipping if stored properly. | ||
Product Specific References | 1. J. Biol. Chem. 1971. 246(18): 5770-5784. |
品牌介绍
加拿大免疫化学药剂有限公司(ImmuneChem Pharmaceuticals Inc. 简称ICP) 是由加拿大政府资助而创立的生物高科技开发公司。始创立于1997年，公司的研究与开发部门位于加拿大不列颠斯哥伦比亚省大温哥华地区。ICP是一个以蛋白质化学技术和免疫技术为基础的免疫化学药物高科技公司。以固相表面化学技术为基础，以蛋白质分离提纯基础为核心，以免疫技术为应用，致力于开发科研和诊断用免疫球蛋白以及医疗用被动免疫球蛋白，其所创建的ImmuneChem品牌抗体试剂多年来畅销世界各地。
联络我们
